Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients

Journal of Chemotherapy

Volumn 9, Issue 2, 1997, Pages 95-101

  Laszlo, D ^a   Bacci, S ^a   Bosi, A ^a,b   Fanci, R ^a   Guidi, S ^a   Saccardi, R ^a   Vannucchi, A M ^a   Ferrini, P Rossi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

BMT; bone marrow transplant; ceftazidime; febrile neutropenia; imipenem cilastatin; netilmicin

Indexed keywords

CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; NETILMICIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS;

EID: 0030968933     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1997.9.2.95     Document Type: Article

References (18)

1. Menichetti F, Del Favero A. The role of gram-positive therapy in the neutropenic patient. J Antimicrob Chemother 1991; 27 (Suppl B): 51-60.
2. Steiner M, Villablanca J, Kersey J et al. Alpha-streptococcal shock in bone marrow transplantation patients. Blood 1988; 72 (Suppl 1): 409A.
3. Hughes WT, Bodey GP, Feld R et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381-396.
4. Sanders JW, Powe NR, Moore RD. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis. J Infect Dis 1991; 164: 907-916.
5. Huijgens PC, Ossenkoppele GJ, Weijers TF et al. Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematological malignancies. Eur J Haematol 1991; 46: 42-46.
6. Freifeld AG, Walsh T, Marshall D et al. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol 1995; 13: 165-176.
7. Joshi JH, Newman KA, Brown BW et al. Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. Supp Care Cancer 1993; 1: 186-194.
8. Studena M, Hlavacova E, Hel'pianska L et al. Teicoplanin plus pefloxacine versus teicoplanin plus netilmicin in empiric therapy of febrile patients with cancer and neutropenia. Chemotherapy 1994; 40 (6): 431-434.
9. Rodzinski E, Kern WV, Reichle A et al. Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients. J Antimicrob Chemother 1993; 31 (4): 585-598.
10. Johnson PR, Liu-Yin JA, Tooth-JA. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients. J Antimicrob Chemother 1992; 30 (2): 203-214.
11. Thomas JF, Hernandez LM, Penarrubia MJ et al. Early bacterial infections in 103 patients treated with bone marrow transplantation. Sangre-Barc 1994; 39 (3): 191-196.
12. Leong WA, Jewesson PJ. A retrospective evaluation of imipenem use in bone marrow transplant patients. Clin Ther 1994; 16 (5): 753-766.
13. EORTC, International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteriemia in cancer patients with granulocytopenia. N Engl J Med 1987; 317: 1692-1698.
14. Lipman B, Neu HC. Imipenem, a new carbapenem antibiotic. Med Clin N Am 1988; 7: 567-579.
15. Bosi A, Fanci R, Guidi S et al. Environmental control measures in a new Bone Marrow Transplant Unit. Haematologica (Suppl 73): 1988; 3: 238.
16. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735.
17. Wilson WH, Jain V, Bryant G et al. Phase I and II study of high-dose ifosfamide, carboplatin and etoposide with autologous bone marrow rescue in lymphomas and solid tumors. J Clin Oncol 1992; 10 (11): 1712-1722.
18. Kojima A, Shinkai T, Soejima Y et al. A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients. Am J Clin Oncol 1994; 17 (5): 400-404.